Version 1
: Received: 17 May 2024 / Approved: 20 May 2024 / Online: 20 May 2024 (13:07:32 CEST)
How to cite:
Yagüe-Caballero, C.; Casas-Deza, D.; Espina-Cadena, S.; Pascual-Oliver, A.; Arbones-Mainar, J. M.; Bernal–Monterde, V. Masld-Related Hepatocarcinoma: Special Features And Challenges. Preprints2024, 2024051278. https://doi.org/10.20944/preprints202405.1278.v1
Yagüe-Caballero, C.; Casas-Deza, D.; Espina-Cadena, S.; Pascual-Oliver, A.; Arbones-Mainar, J. M.; Bernal–Monterde, V. Masld-Related Hepatocarcinoma: Special Features And Challenges. Preprints 2024, 2024051278. https://doi.org/10.20944/preprints202405.1278.v1
Yagüe-Caballero, C.; Casas-Deza, D.; Espina-Cadena, S.; Pascual-Oliver, A.; Arbones-Mainar, J. M.; Bernal–Monterde, V. Masld-Related Hepatocarcinoma: Special Features And Challenges. Preprints2024, 2024051278. https://doi.org/10.20944/preprints202405.1278.v1
APA Style
Yagüe-Caballero, C., Casas-Deza, D., Espina-Cadena, S., Pascual-Oliver, A., Arbones-Mainar, J. M., & Bernal–Monterde, V. (2024). Masld-Related Hepatocarcinoma: Special Features And Challenges. Preprints. https://doi.org/10.20944/preprints202405.1278.v1
Chicago/Turabian Style
Yagüe-Caballero, C., José M Arbones-Mainar and Vanesa Bernal–Monterde. 2024 "Masld-Related Hepatocarcinoma: Special Features And Challenges" Preprints. https://doi.org/10.20944/preprints202405.1278.v1
Abstract
Metabolic Associated Steatohepatitis Liver Disease (MASLD) currently impacts a quarter of the global population and its prevalence is expected to increase in the future. As a result, the incidence of hepatocellular carcinoma associated with MASLD is also on the rise. Notably, hepatocellular carcinoma in this group does not always develop alongside liver cirrhosis, often leading to a more advanced stage at diagnosis. The challenge lies in accurately identifying patients who are at a higher risk of hepatocellular carcinoma to tailor screening processes effectively. Additionally, several therapeutic approaches are being explored to prevent hepatocellular carcinoma, although there are yet no universally accepted guidelines
Medicine and Pharmacology, Gastroenterology and Hepatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
